Qinglan Guo
- Molecular Medicine top 0.2%
- Endocrinology top 1%
- Epidemiology top 10%
- Pharmacology top 2%
- Molecular Biology
- Topics
- Antibiotic Resistance in Bacteria (48 papers)Antibiotics Pharmacokinetics and Efficacy (17 papers)Pneumonia and Respiratory Infections (11 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Qinglan Guo
57 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 76
- Molecular Medicine 1.3k
- Endocrinology 476
- Epidemiology 446
- Pharmacology 378
- Molecular Biology 319
Countries citing papers authored by Qinglan Guo
This map shows the geographic impact of Qinglan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglan Guo more than expected).
Fields of papers citing papers by Qinglan Guo
This network shows the impact of papers produced by Qinglan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglan Guo. The network helps show where Qinglan Guo may publish in the future.
Co-authorship network of co-authors of Qinglan Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Qinglan Guo. A scholar is included among the top collaborators of Qinglan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglan Guo. Qinglan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 10 | |
| 5 | 9 | |
| 6 | 3 | |
| 7 | 34 | |
| 8 | 19 | |
| 9 | 39 | |
| 10 | 12 | |
| 11 | 75 | |
| 12 | 33 | |
| 13 | 10 | |
| 14 | 50 | |
| 15 | 5 | |
| 16 | 16 | |
| 17 | 29 | |
| 18 | 85 | |
| 19 | 13 | |
| 20 | 270 |
About Qinglan Guo
Qinglan Guo is a scholar working on Molecular Medicine, Endocrinology and Microbiology, having authored 57 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Pneumonia and Respiratory Infections (11 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Endocrinology (476 citations) and Applied Microbiology and Biotechnology (96 citations). Qinglan Guo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Minggui Wang, Xiaogang Xu, Xinyu Ye, Minghua Wang, David C. Hooper, Xiaoying Wang, Shi Wu, Yohei Doi, Fupin Hu and Christi L. McElheny. Their work appears in journals such as PLoS ONE, Journal of Clinical Microbiology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.